Redhill Biopharma Ltd (RDHL)

NASDAQ

$0.70

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company is headquartered in Tel Aviv, Israel.

Website: https://www.redhillbio.com

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Target: $19,000 (+2714185.71%)

Market Cap

$5.20M

Beta (5Y)

-0.50

Price Chart

Adjust inflation

Log

Valuation

Market Cap$5.20M

Forward P/E1428.57

P/S0.54

P/B200.52

Profitability

Total Revenue (TTM)$9.55M

Gross Profit (TTM)$286K

EBITDA-$8.34M

Profit Margin-97.5%

Operating Margin-107.3%

Growth & Risk

Beta (5Y)-0.50

Sharpe Ratio-0.84